Gain Therapeutics Company
![](/files/companies/Gain%20Therapeutics.jpg)
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Headquarters:
Bethesda, Maryland, United States
Total Funding:
14396508.0
Founded Date:
2017-01-01
Last Funding Type:
Series B
Investors Number:
6.0
Last Funding Date:
2020-07-21
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Industry:
Preclinical Development